Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology
about
Biomarkers of Parkinson's disease: present and futureThe MiRNA Journey from Theory to Practice as a CNS BiomarkerDiagnostic Value of microRNA for Alzheimer's Disease: A Systematic Review and Meta-AnalysismicroRNA-Based Biomarkers and the Diagnosis of Alzheimer's DiseaseTranscriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson's Disease.Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic ReviewNIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface.Survey of 800+ data sets from human tissue and body fluid reveals xenomiRs are likely artifacts.Serum MicroRNAs Reflect Injury Severity in a Large Animal Model of Thoracic Spinal Cord InjuryAnalysis of extracellular RNA in cerebrospinal fluidThe Identification of Circulating MiRNA in Bovine Serum and Their Potential as Novel Biomarkers of Early Mycobacterium avium subsp paratuberculosis Infection.Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.MicroRNA expression profiles differentiate chronic pain condition subtypes.Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer diseaseTargeted deletion of miR-132/-212 impairs memory and alters the hippocampal transcriptome.microRNA Profiles in Parkinson's Disease Prefrontal CortexmiRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer's disease and other types of dementia - an exploratory study.Biomarkers in Parkinson's disease: Advances and strategies.MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer's disease patients from non-demented subjects.Causes and Consequences of MicroRNA Dysregulation in Neurodegenerative Diseases.Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson's Disease.microRNAs as neuroregulators, biomarkers and therapeutic agents in neurodegenerative diseases.MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.MiR-144-3p and Its Target Gene β-Amyloid Precursor Protein Regulate 1-Methyl-4-Phenyl-1,2-3,6-Tetrahydropyridine-Induced Mitochondrial Dysfunction.Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Mechanisms of Melatonin in Alleviating Alzheimer's Disease.MicroRNAs in Human Cerebrospinal Fluid as Biomarkers for Alzheimer's Disease.MicroRNA-511 Binds to FKBP5 mRNA, Which Encodes a Chaperone Protein, and Regulates Neuronal Differentiation.Specific small-RNA signatures in the amygdala at premotor and motor stages of Parkinson's disease revealed by deep sequencing analysis.A review of genome-wide transcriptomics studies in Parkinson's disease.Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease.Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases.MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review.Exercise - induced changes in cerebrospinal fluid miRNAs in Gulf War Illness, Chronic Fatigue Syndrome and sedentary control subjects.Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis.
P2860
Q24170134-61270BEA-6DF7-4E8B-B616-FBDDE2EDC9E9Q26767457-CA0EECE1-58CD-41DD-ABE7-817671CB2A30Q26768181-A73A73E3-B8C5-4E16-9CA1-9AA90BBB67BFQ26798619-14497F1E-2896-4DA2-ABEA-6321F0BAD814Q27333599-68B6B65A-63AB-4A95-BB2E-D70EDD8C1AD7Q28080047-09A7E4EE-5976-46FA-B74E-2E73E72F3DD8Q30352890-F52F92D3-F2BF-4BF5-A4D5-BD74A95BC01FQ30840984-711FE196-330A-48E7-83A1-F08BDC51F411Q33684070-DA52DB80-CD80-4403-BA3E-C0A760C18573Q33893280-0BE566CB-FCCF-476D-8952-0A497A1DC0F8Q35720244-745C2ABF-9D0F-4DB9-9645-B9EBAA6AB04FQ35870894-5E03C808-FFF6-4CA6-B07F-B081B3C6E45DQ36121377-4DFC33F6-9274-4068-A24C-987048001029Q36307621-7EE1C6FA-D776-4F2D-8F81-420A80B764D6Q36545671-941D0E2A-C91C-4AEE-A105-64DD694495BCQ36569086-E27A4980-9B52-4685-9CD4-B54DAD460DCDQ36634755-6B82A451-C23F-4B81-AA2F-647679E39220Q36687147-C5AB885E-7649-452A-A8BF-024906ADC4D0Q37431507-122157E2-6497-4008-8EB4-47D9E1760AF7Q37702119-443D57F3-8060-4007-AD7A-6A705619C060Q37725397-C8B55545-701B-46B1-BBC4-423C8B9F5D5EQ38224066-69401078-8CC0-4F66-8541-96CBA9E37E83Q38431496-DAF8FAB5-9555-4E42-A355-D50EE032B8A1Q38648154-A4B6319F-1B62-45D2-AA4D-CF56F6627817Q38749271-0FEB427C-FE39-4D34-81DA-C79572C92888Q38762971-23A6277F-6811-4B6D-99A0-01DA60B073F7Q38765914-4E0E0264-FED9-44B8-A9C9-C52831B28118Q38887384-BC8879F7-8355-4E0E-83C0-BF49A970788EQ39010887-5C915894-94C0-4CA7-83A9-47EFB6171221Q39178920-C7ACB606-8C55-4264-9DAE-8F5BF483D3BDQ39215093-83270E0C-7CED-41AC-985F-2927D4B3418DQ39661779-7432CE88-C781-418A-973F-1CD92ABBE194Q40360134-196D42AB-2CDB-4A49-B049-32C15425DCDBQ42778276-733CFCF1-B840-4763-8AAD-A7D0E71E4E10Q43154122-207B1C15-B825-4EA0-9936-0D793D995BFAQ45325968-810443CF-99D6-4D42-9DF7-4C5B7AEC0AF6Q47102033-A9CAFC87-AA99-455E-BD3C-A0CD6C249285Q47111758-8CA127E8-BA64-45D0-A55C-21EAC41BD8EBQ47123147-207D91CB-1DB0-4AFB-8ACF-AEBA442B3332Q47550368-F5B51A9D-F28A-4391-A8D1-CD12CEBA6EA4
P2860
Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Profiles of extracellular miRN ...... atus and features of pathology
@ast
Profiles of extracellular miRN ...... atus and features of pathology
@en
Profiles of extracellular miRN ...... tus and features of pathology.
@nl
type
label
Profiles of extracellular miRN ...... atus and features of pathology
@ast
Profiles of extracellular miRN ...... atus and features of pathology
@en
Profiles of extracellular miRN ...... tus and features of pathology.
@nl
prefLabel
Profiles of extracellular miRN ...... atus and features of pathology
@ast
Profiles of extracellular miRN ...... atus and features of pathology
@en
Profiles of extracellular miRN ...... tus and features of pathology.
@nl
P2093
P2860
P50
P921
P1433
P1476
Profiles of extracellular miRN ...... atus and features of pathology
@en
P2093
Amanda Courtright
Benjamin Rakela
David Craig
Holly Shill
Kasandra Burgos
Kendall Van Keuren-Jensen
Marwan Sabbagh
Raghu Metpally
Stephen Villa
Waibhav Tembe
P2860
P304
P356
10.1371/JOURNAL.PONE.0094839
P407
P577
2014-05-05T00:00:00Z